Effects of epidermal growth factor receptor‐tyrosine kinase inhibitors alone on EGFR‐mutant non‐small cell lung cancer with brain metastasis

BACKGROUND: Epidermal growth factor receptor‐tyrosine kinase inhibitors (EGFR‐TKIs) are remarkably effective for treating EGFR‐mutant non‐small cell lung cancer (NSCLC). However, the individual role of EGFR‐TKIs in patients with brain metastasis (BM) arising from EGFR‐mutant NSCLC remains unclear. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qiuyi, Zhang, Xuchao, Yan, Honghong, Jiang, Benyuan, Xu, Chongrui, Yang, Jinji, Chen, Zhihong, Su, Jian, Wu, Yi‐Long, Zhou, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5093172/
https://www.ncbi.nlm.nih.gov/pubmed/27755835
http://dx.doi.org/10.1111/1759-7714.12379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5093172/
https://www.ncbi.nlm.nih.gov/pubmed/27755835
http://dx.doi.org/10.1111/1759-7714.12379

Ejemplares similares